OBJECTIVE: To explore the feasibility for liver contrast-enhanced CT scan with low dose of radiation and contrast agent in clinical.
 METHODS: A total of 180 cases were randomly divided into group I (low concentration of contrast agent, 270 mgI/mL of iodixanol) and group II (high concentration of contrast agent, 320 mgI/mL of iodixanol). Three scan conditions (A: 120 kV, 300 mA; B: 100 kV, 400 mA; and C: 100 kV, 300 mA) were randomly distributed in 3 phases (arterial phase, venous phase and delay phase) for liver scans in each group. The effective radiation dose (ED), image CT values and quality of images (image of noise (NI), the image signal to noise ratio (SNR), contrast to noise ratio (CNR), and overall image quality (OIQ) scores were recorded and analyzed. 
 RESULTS: ED values for the group C in the total samples were decreased by 38%, 40% and 41%, respectively compared to the group A in contrast-enhanced scan for 3 phases. The image quality was significantly different (P<0.05); ED values in the group B were decreased by 18%, 20% and 20%, respectively compared to group A in contrast-enhanced scan for 3 phases, and there were no significant differences (P>0.05) in image quality. There were significant differences between the group I and the group II in CT values at the same scanning parameters and scanning phases (P<0.05), but the image quality was not obviously different; there was no significant difference between the group A-II and the group B-I as well as the group C-I in image CT values, and there was also no significant difference between the group A-II and the group B-I in image quality (P>0.05); however the differences in image quality were statistically significant between the group A-II and the group C-I (P<0.05).
 CONCLUSION Reduction of the tube voltage (to improve the tube current) combined with the low-dose contrast agent can not only reduce the radiation dose and contrast agent dose but also meet the needs of double-low liver contrast-enhanced CT scan.
Contrast Media ; administration & dosage ; Feasibility Studies ; Humans ; Liver ; pathology ; Radiation Dosage ; Signal-To-Noise Ratio ; Tomography, X-Ray Computed ; Triiodobenzoic Acids ; administration & dosage

Intravenous contrast medium (ICM) rarely induces anaphylactic reactions, including urticaria, hypotension and respiratory failure. Even the most modern ICM may cause such adverse events. Thrombocytopenia has been reported as an extreme rare consequence of ICM. Here we report on a case of a 72-year-old male patient with a self-limiting severe acute thrombocytopenia following administration of intravenous non-ionic low-osmolarity contrast medium. No such low platelet count has ever been reported. We also present a review of the literature.
Aged ; Comorbidity ; Contrast Media/*administration & dosage/*adverse effects/chemistry ; Diagnosis, Differential ; Humans ; Injections, Intravenous ; Kidney Diseases/radiography ; Male ; Osmolar Concentration ; Thrombocytopenia/*chemically induced ; Tomography, X-Ray Computed ; Triiodobenzoic Acids/*administration & dosage/*adverse effects/chemistry

OBJECTIVE: The purpose of this study is to determine the effects of propranolol on the left ventricular (LV) volume during CT coronary angiography. MATERIALS AND METHODS: The LV volume of 252 normal Chinese subjects (126 subjects with propranolol medication and 126 age- and gender-matched Chinese subjects without medication) was estimated using 64 slices multi-detector CT (MDCT). The heart rate difference was analyzed by the logistic linear regression model with variables that included gender, age, body height, body weight, systolic blood pressure (SBP), diastolic blood pressure (DBP) and the dosage of propranolol. The following global LV functional parameters were calculated: the real-end diastolic volume (EDV), the real-end systolic volume (ESV) and the real-ejection fraction (EF). RESULTS: The female subjects had a greater decrease of heart rate after taking propranolol. The difference of heart rate was negatively correlated with the dosage of propranolol. The real-EDV, the real-ESV and the real-EF ranged from 48.1 to 109 mL/m2, 6.1 to 57.1 mL/m2 and 41% to 88%, respectively. There was no significant difference in the SBP and DBP between the groups without and with propranolol medication (123 +/- 17 and 80 +/- 10 mmHg; 120 +/- 14 and 80 +/- 11 mmHg, respectively). The real-EDV showed no significant difference between these two groups, but the real-ESV and real-EF showed significant differences between these two groups (69.4 +/- 9.3 and 70.6 +/- 8.9 mL/m2; 23.5 +/- 5.7 and 25.6 +/- 3.7 mL/m2, 66.5 +/- 5.1% and 63.5 +/- 4.6%, respectively). CONCLUSION: The difference of heart rate is significantly influenced by gender and the dosage of propranolol. Propranolol will also increase the ESV, which contributes to a decreased EF, while the SBP, DBP and EDV are not statistically changed.
Adrenergic beta-Antagonists/*administration & dosage ; Case-Control Studies ; China ; Contrast Media/diagnostic use ; *Coronary Angiography ; Diastole ; Electrocardiography ; Female ; Heart Rate/*drug effects ; Humans ; Logistic Models ; Male ; Middle Aged ; Propranolol/*administration & dosage ; Radiographic Image Interpretation, Computer-Assisted ; Systole ; *Tomography, X-Ray Computed ; Triiodobenzoic Acids/diagnostic use ; Ventricular Function, Left/*drug effects